Last reviewed · How we verify

NCT03586193

Pars Plana Vitrectomy Alone in the Treatment of Macular Schisis in High Myopic Eyes

Status unknown Last updated 13 July 2018
What this trial tests

trial testing Pars plana vitrectomy in Retinal Disease in 40 participants. Status unknown.

Timeline
1 May 2018
Primary endpoint
31 December 2018
31 May 2019

Quick facts

Lead sponsorAier School of Ophthalmology, Central South University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment40
Start date1 May 2018
Primary completion31 December 2018
Estimated completion31 May 2019
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Aier School of Ophthalmology, Central South University

Who can join

Eligibility, any sex, with Retinal Disease or Macular Retinoschisis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High myopic schisis (HMF) has the clinical feature of separation between retinal layers. It is sometimes accompanied with foveal retinal detachment, macular lamellar hole, epiretinal membrane and vitreous retraction. HMF may develop to macular hole, macular detachment and will damage the visual function. Pars plana vitrectomy (PPV) is a commonly used surgery in the treatment of HMF. PPV together with internal limiting membrane (ILM) peeling and long-term gas tamponade was reported to be safe and effective. But nowadays there was no available long-term gas in our country. Also, whether ILM peeling is necessary remains controversial, Indole cyanine green (ICG)was proved to have potential toxicity to the retina and the ILM peeling has the risk of causing secondary macular hole. We propose to make a prospective nonrandomized controlled study to evaluate the safety and efficiency of using PPV alone in the treatment of HMF.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pars plana vitrectomy

Trials testing the same drug.

Other recruiting trials for Retinal Disease

Currently open trials in the same condition.

Other Aier School of Ophthalmology, Central South University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03586193.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing